Trials / Unknown
UnknownNCT04383652
Collection of Coronavirus COVID-19 Outbreak Samples in New South Wales
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Kirby Institute · Other Government
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
The objectives of this study are to characterise immune responses in people with CoV-SARS-2 infection and use this knowledge to advance vaccine design, treatment options, and diagnostic reagents. Eligible participants will include people diagnosed with SARS-CoV-2 infection, and may include recently returned travellers and non-travellers in the community presenting to tertiary hospital healthcare facilities. Recruitment will be opportunistic, and sampling intensity may vary depending on the phase of the outbreak. Participants can be enrolled at any timepoint (up to 6 months) following diagnosis of SARS-CoV-2 infection (COVID-19). Blood samples and clinical data will be collected.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Biological sample and clinical data collection | Plasma and serum will be collected at day 0, day 7, day 14, 1 month and 4 months post diagnosis. Clinical data related to COVID-19 diagnosis, symptoms, and outcomes will be collected. |
Timeline
- Start date
- 2020-05-06
- Primary completion
- 2022-06-30
- Completion
- 2022-06-30
- First posted
- 2020-05-12
- Last updated
- 2021-06-29
Locations
9 sites across 1 country: Australia
Source: ClinicalTrials.gov record NCT04383652. Inclusion in this directory is not an endorsement.